We are monitoring the impact of COVID-19 on Injectable Drug Delivery Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 2015
Share on
Share on

Global Injectable Drug Delivery Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – By Device Type, Formulation, Therapeutic Use, End User & Region - Industry Forecast (2020 to 2025)

Pulished: February, 2020
ID: 2015
Pages: 175

Injectable Drug Delivery Market Size (2020 to 2025)

The size of the global injectable drug delivery market was worth USD 4484.5 million in 2020. This value is estimated to be growing at a CAGR of 11.5% between 2020 to 2025 and worth USD 67846.3 million by 2025.

Injectable Drug Delivery (IDD) is a way to get drugs or medicine into your bloodstream directly. This method is only done with a fluid form of drugs, and it is done with a hollow hypodermic needle and a syringe. The injectable drug delivery was mostly used by patients who need to take pills daily, like diabetic patients. These are most helpful for comatose and unconscious patients. This medication method is accepted because of the fast onset reactions with high adequacy. Cancer and Diabetics patients are the higher share providers in this market. 

MARKET DRIVERS:

Y-O-Y growth in biologics is majorly expected to accelerate the growth of the global injectable drug delivery market, along with the growth in demand for insulin, human growth hormone, vaccines, and most modern medicines for the treatment of cancer and also other chronic diseases. The World Health Organization (WHO) stated that by the end of 2020, chronic diseases would increase by 57%, due to which the medical industries will concentrate on advanced drug delivery technology.

The global injectable drug delivery market is predicted to register significant growth during the forecast period. The increase in diabetic patients over the years is one of the primary drivers of market growth. The year-over-year growth in biologics is expected to boost the growth rate of the global injectable drug delivery market. The technology innovations such as dual injectables are fueling the market. Moreover, the increase in demand for insulin, human growth hormone, vaccines, and most modern medicines for cancer treatment and few more chronic diseases are the primary reason for market growth. The increase in demand for self-injection devices was playing a significant role.

The foremost opportunity would be the new technological innovation by the researchers. Moreover, the increase in the aging population all over the world will help the market growth. Plastics in the injectable drug delivery market are the significant opportunities for the market's growth.

MARKET RESTRAINTS:

Product recalls are the major restraints for the injectable drug delivery market. The market needle stick injuries and infections are hindering the market. Some drug deliveries will not mix into the blood thoroughly, leading to some other health issues. The device's high cost and the lack of reimbursement policies will restrain the market in few years. 

The drug delivery systems Nanoparticles made of certain substances may react with the cellular membranes leads to morphological changes. The lack of awareness on injectable drug delivery devices in developing countries is the major challenge.

Impact of COVID-19 on the global injectable drug delivery market:

COVID-19 is a deadly disease that ruined many lives in distinct ways. All the sectors have faced difficulties with sustaining in the market during this time. With the surging cases of the COVDI 19 in the first half of 2020, all the hospitals and clinics were given priority to the COVID 19 patients where all the other treatment procedures were postponed or canceled. The injectable drug delivery market faced certain challenges during the lockdown period. However, with the decreasing incidences of the coronavirus globally, all the activities are resumed by following preventive measures issued by World Health Organization (WHO). Since coronavirus is not over yet, it must take preventive measures in the hospitals to lower the risk for the patients suffering from chronic diseases. The market shares are expected to have significant growth in the forecast period. 

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Analysed

By Device Type, Formulation, Therapeutic Use, End User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Companies Analysed

Antares Pharmaceuticals Ltd, Baxter International, Becton Dickinson Company, Elcam Medical, Eli Lily and Company, Unilife Corporation, and West Pharmaceutical Inc.

 

This research report on the global injectable drug delivery market has been segmented and sub-segmented based on the device type, formulation, therapeutic use, end-user, and region.

Injectable Drug Delivery Market - By Device Type:

  • Self-Injection Devices
  • Conventional Devices

Based on device type, the conventional devices were dominating the global injectional drug delivery market. The growing prevalence of infectious diseases and increase in hospitalization fueled the market growth. The rise in immunization programs all around the world boosted the market. For instance, in 2019, the Indian government had initiated a vaccination drive to fight against eight diseases. The Self-Injection Devices were rapidly increasing during the forecast period. The innovations in self-injectable devices are propelling the market growth.

Injectable Drug Delivery Market - By Formulation:

  • Conventional Drug Delivery
  • Novel Drug Delivery

Based on Formulation, the novel drug delivery segment is forecasted to dominate the global injectable drug delivery market.  The increase in R&D investments is fueling the market. Conventional drug delivery was growing prominently during the forecast period.

Injectable Drug Delivery Market - By Therapeutic Use:

  • Autoimmune Disorders
  • Hormonal Disorders
  • Oncology

Based on the therapeutic use, the hormonal disorders segment is predicted to record the highest share in the outlook period by the therapeutics application because of the rise in demand for treatment of such diseases. 

Injectable Drug Delivery Market - By End User:

  • Hospitals
  • Homecare Settings
  • Research Institutes
  • Clinical Laboratories

Based on the End-User, the highest share is expected to be contributed by the hospitals and clinics segment with high dominancy during the foreseen period due to the high prevalence of chronic diseases and advanced technologies development. Moreover, technological advancements are boosting the market. The research institutes were estimated to register a high market share in the coming years.

Injectable Drug Delivery Market - By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Geographically, the global injectable drug delivery market was dominated by North America, with an overall market share of over 35% globally. The domination of North America in the global market is majorly driven by the high rise of innovative injectable medical products among patients suffering from chronic diseases like diabetics, cancer, and other autoimmune disorders. Additionally, major numerous companies in nations like the USA and Canada support the expansion of the regional market.  The major share contributors of North America were the United States and Canada. The US was estimated to register USD 624.5 billion by 2021 with a CAGR of 11.5% during the forecast period. The increase in chronic diseases in North America propelling the market. Moreover, the rise in demand for self-injection devices is fueling the market. The increasing aging population was helping the market growth. Moreover, according to The Economist, more than 900 biologics were developing to treat approximately 100 diseases. 

Europe and Asia-Pacific followed North America. The European Injectable Drug Delivery Market is expected to have a higher CAGR during the forecast period. The European Injectable Drug Delivery Market had registered USD 1123 million in 2020. It is expected to grow at a CAGR of 11.90%, to reach USD 1970 million by 2025. The factors such as technological advances for devices are the major factors of European market growth. The increasing awareness of injectable drug delivery devices is fuelling the market.

The Asia Pacific is predicted to grow rapidly in the coming few years because of the rising prevalence of chronic diseases with the need for medical bases and the rise of awareness among the public about the delivery of drug delivery systems. The Asia Pacific is predicted to grow rapidly in the coming few years. In 2020, the Asia Pacific injectable drug delivery registered USD 10437.4 million, and it is estimated to be growing at a CAGR of 12.15% and worth 18794.1 million by 2025. China, India, and Japan are the major contributors to the Asia Pacific fast growth. The increase in diseases and diabetes are the significant factors of the market growth. The manufacturing cost and the easy government permissions are attracting investors, which helps the market growth. Moreover, consistency to novel advancements in the Asia Pacific is fuelling the market. 

KEY MARKET PLAYERS:

Prominent companies dominating the global injectable drug delivery market profiled in this report are Alkermes Inc., Bend Research, BIND Biosciences, Inc., Endocyte, Genentech Inc., MicroCHIPS, Inc., Pearl Therapeutics Inc., Polymer Factory, Presage Bioscience, QLT Inc. and UCB Group.

The global injectable drug delivery market has consolidated competition due to the robust product portfolio and solid distribution network across the globe.

Notable happenings in this market in the recent past:

  • In 2016, a partnership had been made between Gerresheimer and Taisei Medical Co. Ltd. for the extension of ClearJect syringes and providing supportiveness to customers. This further helps to expand the product portfolio and the customer base in the syringe market.
  • In 2015, a collaboration was made by Eli Lilly and Company with Sandford-Burnham Medical Research Institute to develop immunology therapies by focusing on Sjogren's syndrome, lupus, other autoimmune disorders, and inflammatory bowel diseases. This further helps to combine the expertise of both organizations for the treatment of diseases.
  • In 2014, a collaboration was made by Terumo Corporation with Ypsomed Group as it is a company of integration with refillable polymer syringe name as PLAJEX with YpsoMate. This further helped to strengthen the portfolio of products by offering syringes in the injectable drug delivery market.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Device Type                               

                                5.1.1 Introduction           

                                5.1.2 Self-injection Devices         

                                5.1.3  Conventional Devices        

                                5.1.4  Y-o-Y Growth Analysis, By Device Type      

                                5.1.5  Market Attractiveness Analysis, By Device Type    

                                5.1.6  Market Share Analysis, By Device Type     

                5.2 Formulation                               

                                5.2.1 Introduction           

                                5.2.2 Conventional Drug Delivery             

                                5.2.3  Novel Drug Delivery           

                                5.2.4 Y-o-Y Growth Analysis, By Formulation       

                                5.2.5 Market Attractiveness Analysis, By Formulation     

                                5.2.6 Market Share Analysis, By Formulation      

                5.3 Therapeutic Use                       

                                5.3.1 Introduction           

                                5.3.2 Autoimmune Disorders     

                                5.3.3 Hormonal Disorders            

                                5.3.4 Oncology 

                                5.3.5 Y-o-Y Growth Analysis, By Therapeutic Use              

                                5.3.6  Market Attractiveness Analysis, By Therapeutic Use           

                                5.3.7  Market Share Analysis, By Therapeutic Use             

                5.4 End-user                              

                                5.4.1 Introduction           

                                5.4.2 Hospitals  

                                5.4.3 Homecare Settings              

                                5.4.4 Research Institutes             

                                5.4.5 Clinical Laboratories            

                                5.4.6 Other        

                                5.4.7 Y-o-Y Growth Analysis, By End-user

                                5.4.8  Market Attractiveness Analysis, By End-user

                                5.4.9  Market Share Analysis, By End-user

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Device Type

                                                6.1.3.3 By Formulation

                                                6.1.3.4 By Therapeutic Use

                                                6.1.3.5 By End-user

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Device Type

                                                6.1.4.3 By Formulation

                                                6.1.4.4 By Therapeutic Use

                                                6.1.4.5 By End-user

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Device Type

                                                6.1.5.3 By Formulation

                                                6.1.5.4 By Therapeutic Use

                                                6.1.5.5 By End-user

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Alkermes Inc.                            

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Bend Research                          

                8.3 BIND Biosciences Inc.                             

                8.4 Endocyte                     

                8.5 Genentech Inc.                         

                8.6 MicroCHIPS Inc.                        

                8.7 Pearl Therapeutics Inc.                          

                8.8 Polymer Factory                       

                8.9 Presage Bioscience                 

                8.10  QLT Inc.                     

                8.11 UCB Group.                              

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Injectable Drug Delivery Market, By Region, From 2020 to 2025 (USD Million)
  2. Global Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  3. Global Self-injection Devices Market, By Region, From 2020 to 2025 (USD Million)
  4. Global Conventional Devices Market, By Region, From 2020 to 2025 (USD Million)
  5. Global Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  6. Global Conventional Drug Delivery Market, By Region, From 2020 to 2025 (USD Million)
  7. Global Novel Drug Delivery Market, By Region, From 2020 to 2025 (USD Million)
  8. Global Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  9. Global Autoimmune Disorders Market, By Region, From 2020 to 2025 (USD Million)
  10. Global Hormonal Disorders Market, By Region, From 2020 to 2025 (USD Million)
  11. Global Oncology Market, By Region, From 2020 to 2025 (USD Million)
  12. Global Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  13. Global Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  14. Global Homecare Settings Market, By Region, From 2020 to 2025 (USD Million)
  15. Global Research Institutes Market, By Region, From 2020 to 2025 (USD Million)
  16. Global Clinical Laboratories Market, By Region, From 2020 to 2025 (USD Million)
  17. North America Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  18. North America Self-injection Devices Market, By Region, From 2020 to 2025 (USD Million)
  19. North America Conventional Devices Market, By Region, From 2020 to 2025 (USD Million)
  20. North America Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  21. North America Conventional Drug Delivery Market, By Region, From 2020 to 2025 (USD Million)
  22. North America Novel Drug Delivery Market, By Region, From 2020 to 2025 (USD Million)
  23. North America Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  24. North America Autoimmune Disorders Market, By Region, From 2020 to 2025 (USD Million)
  25. North America Hormonal Disorders Market, By Region, From 2020 to 2025 (USD Million)
  26. North America Oncology Market, By Region, From 2020 to 2025 (USD Million)
  27. North America Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  28. North America Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  29. North America Homecare Settings Market, By Region, From 2020 to 2025 (USD Million)
  30. North America Research Institutes Market, By Region, From 2020 to 2025 (USD Million)
  31. North America Clinical Laboratories Market, By Region, From 2020 to 2025 (USD Million)
  32. United States Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  33. United States Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  34. United States Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  35. United States Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  36. Canada Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  37. Canada Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  38. Canada Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  39. Canada Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  40. Europe Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  41. Europe Self-injection Devices Market, By Region, From 2020 to 2025 (USD Million)
  42. Europe Conventional Devices Market, By Region, From 2020 to 2025 (USD Million)
  43. Europe Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  44. Europe Conventional Drug Delivery Market, By Region, From 2020 to 2025 (USD Million)
  45. Europe Novel Drug Delivery Market, By Region, From 2020 to 2025 (USD Million)
  46. Europe Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  47. Europe Autoimmune Disorders Market, By Region, From 2020 to 2025 (USD Million)
  48. Europe Hormonal Disorders Market, By Region, From 2020 to 2025 (USD Million)
  49. Europe Oncology Market, By Region, From 2020 to 2025 (USD Million)
  50. Europe Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  51. Europe Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  52. Europe Homecare Settings Market, By Region, From 2020 to 2025 (USD Million)
  53. Europe Research Institutes Market, By Region, From 2020 to 2025 (USD Million)
  54. Europe Clinical Laboratories Market, By Region, From 2020 to 2025 (USD Million)
  55. U.K. Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  56. U.K. Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  57. U.K. Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  58. U.K. Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  59. Germany Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  60. Germany Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  61. Germany Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  62. Germany Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  63. France Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  64. France Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  65. France Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  66. France Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  67. Italy Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  68. Italy Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  69. Italy Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  70. Italy Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  71. Spain Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  72. Spain Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  73. Spain Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  74. Spain Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  75. Asia-Pacific Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  76. Asia-Pacific Self-injection Devices Market, By Region, From 2020 to 2025 (USD Million)
  77. Asia-Pacific Conventional Devices Market, By Region, From 2020 to 2025 (USD Million)
  78. Asia-Pacific Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  79. Asia-Pacific Conventional Drug Delivery Market, By Region, From 2020 to 2025 (USD Million)
  80. Asia-Pacific Novel Drug Delivery Market, By Region, From 2020 to 2025 (USD Million)
  81. Asia-Pacific Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  82. Asia-Pacific Autoimmune Disorders Market, By Region, From 2020 to 2025 (USD Million)
  83. Asia-Pacific Hormonal Disorders Market, By Region, From 2020 to 2025 (USD Million)
  84. Asia-Pacific Oncology Market, By Region, From 2020 to 2025 (USD Million)
  85. Asia-Pacific Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  86. Asia-Pacific Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  87. Asia-Pacific Homecare Settings Market, By Region, From 2020 to 2025 (USD Million)
  88. Asia-Pacific Research Institutes Market, By Region, From 2020 to 2025 (USD Million)
  89. Asia-Pacific Clinical Laboratories Market, By Region, From 2020 to 2025 (USD Million)
  90. Japan Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  91. Japan Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  92. Japan Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  93. Japan Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  94. China Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  95. China Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  96. China Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  97. China Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  98. India Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  99. India Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  100. India Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  101. India Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  102. Australia Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  103. Australia Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  104. Australia Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  105. Australia Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  106. South Korea Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  107. South Korea Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  108. South Korea Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  109. South Korea Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  110. Latin America Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  111. Latin America Self-injection Devices Market, By Region, From 2020 to 2025 (USD Million)
  112. Latin America Conventional Devices Market, By Region, From 2020 to 2025 (USD Million)
  113. Latin America Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  114. Latin America Conventional Drug Delivery Market, By Region, From 2020 to 2025 (USD Million)
  115. Latin America Novel Drug Delivery Market, By Region, From 2020 to 2025 (USD Million)
  116. Latin America Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  117. Latin America Autoimmune Disorders Market, By Region, From 2020 to 2025 (USD Million)
  118. Latin America Hormonal Disorders Market, By Region, From 2020 to 2025 (USD Million)
  119. Latin America Oncology Market, By Region, From 2020 to 2025 (USD Million)
  120. Latin America Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  121. Latin America Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  122. Latin America Homecare Settings Market, By Region, From 2020 to 2025 (USD Million)
  123. Latin America Research Institutes Market, By Region, From 2020 to 2025 (USD Million)
  124. Latin America Clinical Laboratories Market, By Region, From 2020 to 2025 (USD Million)
  125. Brazil Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  126. Brazil Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  127. Brazil Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  128. Brazil Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  129. Argentina Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  130. Argentina Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  131. Argentina Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  132. Argentina Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  133. Mexico Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  134. Mexico Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  135. Mexico Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  136. Mexico Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  137. Rest of Latin America Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  138. Rest of Latin America Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  139. Rest of Latin America Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  140. Rest of Latin America Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  141. Middle East & Africa Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  142. Middle East & Africa Self-injection Devices Market, By Region, From 2020 to 2025 (USD Million)
  143. Middle East & Africa Conventional Devices Market, By Region, From 2020 to 2025 (USD Million)
  144. Middle East & Africa Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  145. Middle East & Africa Conventional Drug Delivery Market, By Region, From 2020 to 2025 (USD Million)
  146. Middle East & Africa Novel Drug Delivery Market, By Region, From 2020 to 2025 (USD Million)
  147. Middle East & Africa Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  148. Middle East & Africa Autoimmune Disorders Market, By Region, From 2020 to 2025 (USD Million)
  149. Middle East & Africa Hormonal Disorders Market, By Region, From 2020 to 2025 (USD Million)
  150. Middle East & Africa Oncology Market, By Region, From 2020 to 2025 (USD Million)
  151. Middle East & Africa Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  152. Middle East & Africa Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  153. Middle East & Africa Homecare Settings Market, By Region, From 2020 to 2025 (USD Million)
  154. Middle East & Africa Research Institutes Market, By Region, From 2020 to 2025 (USD Million)
  155. Middle East & Africa Clinical Laboratories Market, By Region, From 2020 to 2025 (USD Million)
  156. Middle East Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  157. Middle East Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  158. Middle East Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  159. Middle East Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)
  160. Africa Injectable Drug Delivery Market, By Device Type, From 2020 to 2025 (USD Million)
  161. Africa Injectable Drug Delivery Market, By Formulation, From 2020 to 2025 (USD Million)
  162. Africa Injectable Drug Delivery Market, By Therapeutic Use, From 2020 to 2025 (USD Million)
  163. Africa Injectable Drug Delivery Market, By End-user, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample